Preparing for Appraisal

Most pharmaceutical companies now have a very robust appraisal system which measures not only your sales/activity performance but also your skills set. This should...

12 Types of Sales Call Reluctance

In the previous four articles we dealt with the causes of sales call reluctance and how it can dramatically affect the productivity of sales...

The Ultimate Guide To Interview Questions

    Not all interviews are the same, but...

The Customer is Always Right

DEALING WITH DIFFICULT CUSTOMERS As you’ve probably discovered, the old adage “the customer is always right” isn’t always t...

Creating Habits For SUCCESS

  We first make our habits and then our habits make us When you think now about the word...

Under Pressure

     With the economy taking a downward spiral in recent months, it is important for companies to be prepared to...

Going the extra mile

I am sure that we all have our ideas of what constitutes good customer service, after all most...

So Why Do You Want This Job

  Whether you are an old hat at interviews or this is your first time, it can still be a...

Have You Lost It?

  What happens when you are used to being “Number One”, the best sales person in your team and then...

Latest articles

NICE recommendation for UCB’s bimekizumab for the treatment of severe plaque psoriasis

NICE recommendation for UCB’s bimekizumab as treatment for severe plaque psoriasis

The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination, recommending UCB’s bimekizumab as an option for the treatment...
Amanda Pritchard appointed new Chief Executive Officer of NHS England

Amanda Pritchard appointed new Chief Executive Officer of NHS England

The first woman to lead NHS England, Amanda Pritchard, has been appointed and will take up her post on Sunday August 1. She takes...
Study shows AZ’s COVID-19 vaccine did not increase the rate of rare blood clots after second dose

Study shows AZ’s COVID-19 vaccine did not increase rate of rare blood clots after...

Data published in The Lancet has demonstrated that AstraZeneca’s COVID-19 jab Vaxzevria (formerly AZD1222) does not increase the rate of rare blood clots after...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
NICE recommendation for UCB’s bimekizumab for the treatment of severe plaque psoriasis

NICE recommendation for UCB’s bimekizumab as treatment for severe plaque psoriasis

The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination, recommending UCB’s bimekizumab as an option for the treatment...
ABPI Code & digital content myth-busting

ABPI Code & digital content myth-busting

Dr Rina Newton busts some myths to demonstrate the commercial wins when ABPI code compliance is not considered digital content’s arch nemesis. Top ten takeaways 1....
Negotiating the changing NHS landscape: five critical shifts the pharma industry must embrace

Negotiating the changing NHS landscape: five critical shifts the pharma industry must embrace

As the long-awaited Health and Care Bill begins its passage through parliament, Oli Hudson looks at five critical changes resulting from these reforms that...
Nasal spray to protect against COVID-19 is ready for use in humans

Nasal spray to protect against COVID-19 is ready for use in humans

A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription